Human prion diseases: Progress in clinical trials

Brain

Volumn 136, Issue 4, 2013, Pages 996-997

  Zerr, Inga ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ATAXIA; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; FRONTOTEMPORAL DEMENTIA; GENOTYPE; HUMAN; MULTIINFARCT DEMENTIA; NOTE; PATIENT MONITORING; PHENOTYPE; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; SAMPLE SIZE; SPORADIC CREUTZFELDT JAKOB DISEASE; THERAPY EFFECT;

EID: 84876061365     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt075     Document Type: Note

References (8)

1. Braaten AJ, Parsons TD, McCue R, Sellers A, Burns WJ. Neurocognitive differential diagnosis of dementing disease: Alzheimers dementia, vascular dementia, frontotemporal dementia, and major depressive disorder. Int J Neurosci 2006; 116: 1271-93.
2. Heinemann U, Krasnianski A, Meissner B, Varges D, Bartl M, Stoeck K, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007; 130: 1350-9.
3. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-91.
4. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-33.
5. Pocchiari M, Poupolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 10: 2348-59.
6. Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic interventions in human prion diseases. Neurology 2008; 70: 1272-81.
7. Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129: 2241-65.
8. Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schröter A, Henkel K, et al. Current clinical diagnosis in CJD: identification of uncommon variants. Ann Neurol 2000; 48: 323-9.